Mechanistically, KAL induced hepatic steatosis and NASH by down-regulating ATGL and CGI-58 by LRP6/Gɑs/PKA/GSK3β pathway. The gene discussed is PNPLA2; the disease is metabolic dysfunction-associated steatohepatitis.